Tharp William G, Gartner Carlos A, Santos-Ortega Yulica, Vary Calvin P, Bender S Patrick, Dixon Anne E
Department of Anesthesiology, University of Vermont, Burlington, Vermont, United States.
Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, United States.
Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L35-L47. doi: 10.1152/ajplung.00054.2025. Epub 2025 May 27.
Obesity contributes to pulmonary dysfunction through poorly understood biochemical mechanisms. Chronic inflammation and altered cellular metabolism have emerged as pathological changes across organ systems in obesity, but whether similar changes occur in lungs with obesity is unknown. We collected bronchoalveolar lavage fluid (BALF) from right upper lobe and lingula pulmonary subsegments of 14 adults (7 males/7 females) with body mass indexes (BMIs) ranging from 24.3 to 50.9 kg/m without lung disease. Proteomes were measured using sequential window acquisition of all theoretical fragment ion spectra (SWATH) mass spectrometry. Proteomic composition and pathway enrichments were examined for the cohort and as a function of BMI. BALF proteomic compositions were consistent with earlier studies and had improved protein identification. We found minimal differences in BALF proteomes between lavage regions. Five proteins were strongly correlated with BMI (False Detection Rate/FDR-adjusted values < 0.05) and 11 had weaker correlation (FDR-adjusted values 0.05-0.1). These proteins included acute phase reactants and complement factors. Few proteomic differences between biological sexes were detected, but some of them coincided with BMI-related proteins. Pathway enrichments impacted by BMI included innate immunity, antifibrinolysis, oxidative stress, and lipid metabolism. The bronchoalveolar microenvironment is altered by obesity in humans without lung disease. Pathway alterations associated with BMI included coagulation and fibrinolysis, redox and oxidative stress, energy metabolism, and humoral immune function. Our data support the theory that conserved biochemical and cellular changes in obesity may be fundamental mechanisms of dysfunction in multiple tissues but the specific impact on pulmonary function or disease is not yet known. Obesity is thought to cause deleterious changes in lung biochemistry, but data in humans are lacking. We measured the alveolar proteome in bronchoalveolar lavages from subjects with a wide range of body mass index and no lung disease. We found changes in proteins and pathways associated with increasing body mass index that are similar to pathological changes observed in other tissues and may constitute mechanisms of pulmonary dysfunction in obesity.
肥胖通过尚不明确的生化机制导致肺功能障碍。慢性炎症和细胞代谢改变已成为肥胖患者各器官系统的病理变化,但肥胖患者肺部是否发生类似变化尚不清楚。我们收集了14名体重指数(BMI)在24.3至50.9kg/m²之间且无肺部疾病的成年人(7名男性/7名女性)右上叶和舌叶肺亚段的支气管肺泡灌洗液(BALF)。使用所有理论碎片离子光谱的顺序窗口采集(SWATH)质谱法测量蛋白质组。对该队列以及作为BMI函数的蛋白质组组成和通路富集情况进行了检查。BALF蛋白质组组成与早期研究一致,且蛋白质鉴定有所改进。我们发现灌洗区域之间的BALF蛋白质组差异极小。五种蛋白质与BMI高度相关(错误发现率/FDR校正值<0.05),11种蛋白质相关性较弱(FDR校正值0.05 - 0.1)。这些蛋白质包括急性期反应物和补体因子。未检测到生物学性别之间的蛋白质组差异,但其中一些与BMI相关蛋白质一致。受BMI影响的通路富集包括先天免疫、抗纤维蛋白溶解、氧化应激和脂质代谢。在无肺部疾病的人类中,肥胖会改变支气管肺泡微环境。与BMI相关的通路改变包括凝血和纤维蛋白溶解、氧化还原和氧化应激、能量代谢以及体液免疫功能。我们的数据支持这样一种理论,即肥胖中保守的生化和细胞变化可能是多个组织功能障碍的基本机制,但对肺功能或疾病的具体影响尚不清楚。肥胖被认为会导致肺生化的有害变化,但人类数据尚缺。我们测量了体重指数范围广泛且无肺部疾病的受试者支气管肺泡灌洗中的肺泡蛋白质组。我们发现与体重指数增加相关的蛋白质和通路变化与在其他组织中观察到的病理变化相似,可能构成肥胖中肺功能障碍的机制。